NCT03846895

Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB)

The Role of the Micro-ablative Fractional CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: National and Kapodistrian University of Athens · Academic / Other
• Sex: Female
• Age: 40 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the clinical efficacy and symptom relief of vaginal fractional CO2 laser treatment in post-menopausal women with Overactive Bladder syndrome(OAB). Post-menopausal women with OAB syndrome who receive β3 adrenergic receptors (mirabegron 50mg) treatment, will be randomized in two groups. Half participants will receive active CO2 laser therapy, while the other half will receive placebo CO2 laser therapy.

Conditions

• Overactive Bladder (OAB)

Interventions

Type	Name	Description
DEVICE	Microablative Fractional CO2 laser	3 therapies intravaginally administered will be applied at monthly intervals

Timeline

• Start date: 2018-05-12
• Primary completion: 2021-09-15
• Completion: 2022-02-15
• First posted: 2019-02-20
• Last updated: 2022-09-07

Locations

1 site across 1 country: Greece